type here...

CATEGORIES

Press Release

LATEST

1234...12Page 3 of 12

TRENDING

EDITORS CHOICE

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

Medika Life -
The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life -
FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

Telemedicine Market Size Worth $298.9 Billion By 2028 | CAGR: 22.4%: Grand View Research, Inc.

Medika Life -
The global telemedicine market size is expected to reach USD 298.9 billion by 2028, according to a new report by Grand View Research

St. Jude scientists identify possible COVID-19 treatment in the lab

Medika Life -
If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories